Whole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study.

TitleWhole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study.
Publication TypeJournal Article
Year of Publication2017
Authorsde Vries, PS, Yu, B, Feofanova, EV, Metcalf, GA, Brown, MR, Zeighami, AL, Liu, X, Muzny, DM, Gibbs, RA, Boerwinkle, E, Morrison, AC
JournalHum Mol Genet
Volume26
Issue17
Pagination3442-3450
Date Published2017 09 01
ISSN1460-2083
KeywordsAfrican Americans, Alleles, Atherosclerosis, European Continental Ancestry Group, Exome, Female, Gene Frequency, Genetic Association Studies, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Kallikreins, Male, Middle Aged, Peptides, Polymorphism, Single Nucleotide, Proteins, Risk Factors, Whole Genome Sequencing
Abstract

Oligopeptides are important markers of protein metabolism, as they are cleaved from larger polypeptides and proteins. Genetic association studies may help elucidate their origin and function. In 1,552 European Americans and 1,872 African Americans of the Atherosclerosis Risk in Communities study, we performed whole-genome and whole-exome sequencing and measured serum levels of 25 peptides. Common variants (minor allele frequency > 5%) were analysed individually. We grouped low-frequency variants (minor allele frequency ≤ 5%) by a genome-wide sliding window using region-based aggregate tests. Furthermore, low-frequency regulatory variants were grouped by gene, as were functional coding variants. All analyses were performed separately in each ancestry group and then meta-analysed. We identified 22 common variant associations with peptide levels (P-value 

DOI10.1093/hmg/ddx266
Alternate JournalHum Mol Genet
PubMed ID28854705
PubMed Central IDPMC5886054
Grant ListHHSN268201100012C / HL / NHLBI NIH HHS / United States
RC2 HL102419 / HL / NHLBI NIH HHS / United States
HHSN268201100009I / HL / NHLBI NIH HHS / United States
HHSN268201100010C / HL / NHLBI NIH HHS / United States
HHSN268201100008C / HL / NHLBI NIH HHS / United States
HHSN268201100005G / HL / NHLBI NIH HHS / United States
HHSN268201100008I / HL / NHLBI NIH HHS / United States
HHSN268201100007C / HL / NHLBI NIH HHS / United States
HHSN268201100011I / HL / NHLBI NIH HHS / United States
HHSN268201100011C / HL / NHLBI NIH HHS / United States
R01 HL086694 / HL / NHLBI NIH HHS / United States
U01 HG004402 / HG / NHGRI NIH HHS / United States
U54 HG003273 / HG / NHGRI NIH HHS / United States
HHSN268201100006C / HL / NHLBI NIH HHS / United States
HHSN268201100005I / HL / NHLBI NIH HHS / United States
HHSN268201100009C / HL / NHLBI NIH HHS / United States
HHSN268201100005C / HL / NHLBI NIH HHS / United States
HHSN268201100007I / HL / NHLBI NIH HHS / United States